RAB28 Antibody

RAB28, a member of the Rab GTPase family, plays critical roles in intracellular trafficking and disease pathways. Below are structured FAQs addressing key research considerations, supported by experimental evidence from peer-reviewed studies and technical resources.

How to validate RAB28 antibody specificity in diverse experimental models?

Methodological approach:

• Perform knockdown/knockout controls: In T. brucei, RNAi-mediated Rab28 depletion reduced protein levels by ~90%, validated via northern and western blotting . Similarly, Rab28 −/− mice showed no detectable RAB28 in retinal cryosections .

• Use isoform-specific validation: Human RAB28 has three splice variants (V1–V3). Antibodies targeting shared epitopes (e.g., Thermo Fisher PA5-104071 ) should be verified against recombinant isoforms (Fig. 1B in ).

What are the optimal applications for RAB28 antibodies in cell biology studies?

Key applications:

Recommendation: Optimize fixation methods for subcellular localization (e.g., methanol fixation for T. brucei ).

How to troubleshoot cross-reactivity in non-model organisms?

Strategies:

• Compare sequence homology: RAB28 orthologs share >80% identity in human, mouse, and rat . For non-mammalian models (e.g., C. elegans), use antibodies validated in phylogenetically close species.

• Employ negative controls: Use tissues/cells from Rab28 −/− models (e.g., mouse retina ) to confirm signal absence.

How to investigate RAB28’s role in intracellular trafficking pathways?

Experimental design:

• Knockout/RNAi models: In T. brucei, Rab28 depletion impaired lysosomal delivery of trypanolytic factor (41% increased survival in human serum; P<0.005) and delayed ISG75 turnover .

• Trafficking assays: Monitor cargo (e.g., fluorescently tagged TLF or ISG75) in Rab28-deficient cells using live imaging .

How to resolve contradictory data on RAB28’s functional mechanisms?

Case example:

• Specificity confirmation: In T. brucei, Rab28 RNAi effects were distinct from Vps23 silencing (Fig. 4F vs. 4G ).

• Orthogonal validation: Combine RNAi with CRISPR knockout or rescue experiments (e.g., expressing RNAi-resistant Rab28).

How to map RAB28 interaction networks in disease contexts?

Workflow:

• Co-IP/MS: Co-immunoprecipitate RAB28 with partners like PDE6D or KCNJ13 (validated in Fig. 8A ).

• Functional clustering: Use STRING-DB to identify enriched pathways (e.g., vesicle transport or glucose metabolism ).

• Perturbation studies: Test trafficking defects in Rab28 −/− cells expressing mutant interaction partners.

How to detect RAB28 isoforms in tissue-specific contexts?

Approach:

• Isoform-specific antibodies: Target unique C-terminal regions (e.g., V1/V2 vs. V3 ).

• RT-PCR: Amplify variant-specific exons (e.g., exons 7–9 in human RAB28 ).